These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34634057)

  • 1. 3D modelling of drug-coated balloons for the treatment of calcified superficial femoral arteries.
    Colombo M; Corti A; Berceli S; Migliavacca F; McGinty S; Chiastra C
    PLoS One; 2021; 16(10):e0256783. PubMed ID: 34634057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.
    Tzafriri AR; Parikh SA; Edelman ER
    J Control Release; 2019 Sep; 310():94-102. PubMed ID: 31430500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
    JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does a drug-coated balloon work? Overview of coating techniques and their impact.
    Speck U; Stolzenburg N; Peters D; Scheller B
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):3-11. PubMed ID: 26771720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S; Paramasivam G; Mishra S
    Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating Balloon-Vessel Contact Pressure Patterns in Angioplasty: In Silico Insights for Drug-Coated Balloons.
    Stratakos E; Antonini L; Poletti G; Berti F; Tzafriri AR; Petrini L; Pennati G
    Ann Biomed Eng; 2023 Dec; 51(12):2908-2922. PubMed ID: 37751027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy.
    Kolachalama VB; Pacetti SD; Franses JW; Stankus JJ; Zhao HQ; Shazly T; Nikanorov A; Schwartz LB; Tzafriri AR; Edelman ER
    Circulation; 2013 May; 127(20):2047-55. PubMed ID: 23584359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
    Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
    Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
    J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
    Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
    JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the potential limitations of drug coated balloons and possible ways to overcome.
    Werk M
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
    Kolodgie FD; Pacheco E; Yahagi K; Mori H; Ladich E; Virmani R
    J Vasc Interv Radiol; 2016 Nov; 27(11):1676-1685.e2. PubMed ID: 27641674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
    Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK
    Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Biologic Effect and Particulate Embolization after Femoral Artery Treatment with Three Drug-Coated Balloons in Healthy Swine Model.
    Torii S; Jinnouchi H; Sakamoto A; Romero ME; Kolodgie FD; Virmani R; Finn AV
    J Vasc Interv Radiol; 2019 Jan; 30(1):103-109. PubMed ID: 30527654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
    Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
    Bienek S; Kusmierczuk M; Mittag A; Bettink S; Scheller B
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):319-328. PubMed ID: 31696642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Interstitial Fluid Flow on Drug-Coated Balloon Delivery in a Patient-Specific Arterial Vessel with Heterogeneous Tissue Composition: A Simulation Study.
    Sarifuddin ; Mandal PK
    Cardiovasc Eng Technol; 2018 Jun; 9(2):251-267. PubMed ID: 29508375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.